Latest Breaking News On - Sunil singhal - Page 1 : comparemela.com

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery

Vergent Bioscience Presents Phase 2 Data Showing VGT-309 Visualizes Tumors in the Lung During Surgery
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

John santiniSunil singhalVergent bioscience australia pty ltdSociety of thoracic surgeonsNational institutes of healthBioscience presents phaseLung duringAnnual meetingThoracic surgeonsPerelman schoolNational cancer instituteNational institutesProfessor matt bogyoStanford university schoolBioscience australia pty ltd

New treatment from Vergent Bioscience able to visualize tumors in lung during surgery

Biotechnology company Vergent Bioscience has revealed that VGT-309, its investigational tumor-targeted fluorescent imaging agent, is able to help surgeons see lung tumors in real time during surgical procedures.

John santiniSunil singhalSociety of thoracic surgeonsAnnual meetingThoracic surgeonsPerelman schoolBio developmentsEmerging marketsLung cancer

Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons

Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesJohn santiniSunil singhalLaura morganPatrick bou samraNational institutes of healthVergent bioscience australia pty ltdSam brown incUniversity of pennsylvaniaSociety of thoracic surgeonsDivision of surgeryPerelman school of medicineAnnual meetingThoracic surgeonsWilliam maul measey professor

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesJohn santiniSunil singhalVergent bioscience australia pty ltdProduct serviceBioscience initiates phaseEvaluating efficacyTumor targeted fluorescent imaging agentLung cancerWorld conferenceWilliam maul measey professorSurgical researchPennsylvania perelman schoolProfessor matt bogyoStanford university school

Tata Steel Jamshedpur, Meramandali, Kalinganagar receives Value Engineering awards from INVEST

Tata Steel Jamshedpur, Meramandali, Kalinganagar receives Value Engineering awards from INVEST | Corporate News | The Avenue Mail

Chandra mohan vermaSurya prakash prabhakerBijaya kumar sadangiSandeep kumar patilBabu manjunath mogerShyam manohar pandeyTata steelEngineering projects departmentRohitr kanojia member coIshrat mirza team leader authorVikash kumar team leader authorAnkur samadhiya coSubrata ghosh team leaderIndian value engineering societyInternational value engineering conferenceValue engineering